Join Now

Alucent Biomedical Wins FDA Approval for U.S. Clinical Study

By Press Release | Published August 3, 2023

U.S. FDA Grants an Investigational Device Exemption for Trial Evaluating Novel AlucentNVS Technology

Posted in BioUtah News | Tagged | Comments Off on Alucent Biomedical Wins FDA Approval for U.S. Clinical Study

Alucent Biomedical Announces First Patient Enrolled in First in Human Natural Vascular Scaffolding Clinical Trial

By Press Release | Published April 14, 2022

Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Elite Members